1.Pasteur, L. Address to the Fraternal Association of Former Students of the Ecole Centrale des Arts et Manufactures, Paris, France, March 15, 1884.
2.Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982;97:309–317.
3.Wenzel, RP, Schaffner, WA. Of Roman gods and a new journal. Infect Control 1980;1:13.
4.Rhame, FS. Should there be an association of hospital epidemiologists? Infect Control 1980;1:314–318.
5.Decker, MD. Change and constancy. Infect Control Hosp Epidemiol 1993;14:14.
6.Decker, MD. Help wanted. Infect Control Hosp Epidemiol 2000;21:757–759.
7.Weinstein, RA. Controlling VRE and MRSA: standard precautions vs. surveillance cultures and contact precautions. Presented at the 40th Annual Meeting of the Infectious Diseases Society of America; October 24, 2002; Chicago, IL.
8.Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA 2003;290:1899–1905.
9.Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53–59.
10.Blot, SI, Vandewoude, KH, Hoste, EA, Colardyn, FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162:2229–2235.
11.Engemann, JJ, Carmeli, Y, Cosgrove, SE, et al.Adverse clinical and economie outeomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592–598.
12.Jernigan, JA, Clemence, MA, Stott, GA, et al.Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686–696.
13.Verhoef, J, Beaujean, D, Blok, H, et al.A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999;18:461–466.
14.Salmenlinna, S, Lyytikainen, O, Kotilainen, P, Scotford, R, Siren, E, Vuopio-Varkila, J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis 2000;19:101–107.
15.Said-Salim, B, Mathema, B, Kreiswirth, BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003;24:451–455.
16.Leman, R, Alvarado-Ramy, F, Pocock, S, et al.Methicillin-resistant Staphylococcus aureus nasal carriage in an American Indian population, Washington, 2001. Infect Control Hosp Epidemiol. In press.
17.Sa-Leao, R, Sanches, IS, Couto, I, Alves, CR, de Lencastre, H. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microb Drug Resist 2001;7:237–245.
18.Shopsin, B, Mathema, B, Martinez, J, et al.Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000;182:359–362.
19.Grundmann, H, Tami, A, Hori, S, Halwani, M, Slack, R. Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. BMJ 2002;324:1365–1366.
20.Nakamura, MM, Rohling, KL, Shashaty, M, Lu, H, Tang, YW, Edwards, KM. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatrie population. Pediatr Infect Dis J 2002:21:917–922.
21.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al.SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.
22.Boyce, JM, Pittet, D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task. Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR 2002;51(RR-16):1–45.
23.Sehulster, L, Chinn, RY. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003;52(RR-10):1–42.
24.Papia, G, Louie, M, Tralla, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473–477.
25.Bronstein, M, Kaye, K, Sexton, D. Gown utilization as a measure of cost of methicillin resistant Staphylococcus aureus screening. Presented at the 12th Annual Meeting of the Society for Healthcare Epidemiology of America; April 6-9, 2002; Sait Lake City, UT. Abstract: 47:51.
26.Lucet, J, Chevret, S, Durand-Zaleski, I, Chastang Cregnier, B. Prevalence and risk factors for carriage of methicillin resistant Staphylococcus aureus at admission to the intensive care unit. Arch Intern Med 2003;163:181–188.
27.Karchmer, TB, Cage, EG, Durbin, LJ, Simonton, BM, Farr, BM. Cost effectiveness of active surveillance cultures for controlling methicillin-resistant S. aureus (MRSA). J Hosp Infect 2002;51:126–132.
28.Haley, RW, Cushion, NB, Tenover, FC, et al.Eradication of endemie methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614–624.
29.Burke, JP. Infection control—a problem for patient safety. N Engl J Med 2003;348:651–656.